SCHEMBL26547285

SCHEMBL26547285

COc1ccc(CNC(=O)Nc2ccc(CN3CCC(F)CC3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.61
MCHR1 Q99705 3/20 0.60
HRH3 Q9Y5N1 1/20 0.60
CCR3 P51677 1/20 0.60
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
HDAC1 Q13547 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
TSHR P16473 1/20 0.55
HIF1A Q16665 1/20 0.55
EPAS1 Q99814 1/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
POLB P06746 1/20 0.54
CHRM1 P11229 1/20 0.54
HTR2A P28223 1/20 0.54
FAAH O00519 2/20 0.53
ROCK2 O75116 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26101263 0.91 SMN1; SMN2 (0.61) SMN1; SMN2MCHR1HRH3CCR3NPC1
SCHEMBL23747488 0.88 TSHR (0.72) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747448 0.87 CHRM1 (0.69) SMN1; SMN2MCHR1HRH3NPC1RAB9A
SCHEMBL26098498 0.87 SMN1; SMN2 (0.59) SMN1; SMN2MCHR1HRH3CCR3NPC1
SCHEMBL26101062 0.87 SMN1; SMN2 (0.61) SMN1; SMN2MCHR1HRH3CCR3NPC1
SCHEMBL26558192 0.86 SMN1; SMN2 (0.64) SMN1; SMN2MCHR1HRH3CCR3NPC1
SCHEMBL23747801 0.85 CCR3 (0.59) SMN1; SMN2MCHR1HRH3CCR3NPC1
SCHEMBL26547229 0.85 SMN1; SMN2 (0.65) SMN1; SMN2MCHR1HRH3CCR3NPC1
SCHEMBL23747569 0.84 PKM (0.72) SMN1; SMN2MCHR1HRH3CCR3NPC1
SCHEMBL23747572 0.84 SMN1; SMN2 (0.61) SMN1; SMN2MCHR1HRH3CCR3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885MCHR1 358/4885HRH3 647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.